Roche drops Alzheimer drug trials after setback

Roche Holding will halt two late-stage clinical trials of its crenezumab drug for early Alzheimer's disease after an interim analysis indicated it was unlikely to hit its primary goal, the Swiss drugmaker said on Wednesday.

from Reuters: Health News https://reut.rs/2ME2OAN